Literature DB >> 7741568

Cardiomyopathy in respiratory chain disorders.

J Guenthard1, F Wyler, B Fowler, R Baumgartner.   

Abstract

Disorders of mitochondrial oxidative phosphorylation may disturb cardiac energy metabolism and cause cardiomyopathy. Twenty one cases from the literature and one further patient with cardiomyopathy due to biochemically defined respiratory chain defects were reviewed for clinical course, morphology, and pathophysiological mechanisms of the cardiomyopathy. All cases showed concentric hypertrophy of the myocardium without an outflow tract obstruction. In most patients the cardiomyopathy was diagnosed early in infancy and showed rapid deterioration with death before the age of 2 years. Hypertrophy of the myocardium appears to result from swelling of the cardiomyocytes caused by accumulation of mitochondria and by morphologically abnormal megamitochondria.

Entities:  

Mesh:

Year:  1995        PMID: 7741568      PMCID: PMC1511042          DOI: 10.1136/adc.72.3.223

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  34 in total

1.  Foamy myocardial transformation in a child with a disturbed respiratory chain.

Authors:  H Böhles; H Singer; W Ruitenbeek; J M Trijbels; R C Sengers; U P Ketelsen; E Wagner-Thiessen; H Wick
Journal:  Eur J Pediatr       Date:  1987-11       Impact factor: 3.183

Review 2.  Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

Authors:  B J Maron; R O Bonow; R O Cannon; M B Leon; S E Epstein
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

3.  Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport. Fatal infantile lactic acidosis and hypermetabolism with skeletal-cardiac myopathy and encephalopathy.

Authors:  C L Hoppel; D S Kerr; B Dahms; U Roessmann
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

4.  Inherited cardiomyopathies.

Authors:  D P Kelly; A W Strauss
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

5.  Two cases of NADH-coenzyme Q reductase deficiency: relationship to MELAS syndrome.

Authors:  M Kobayashi; H Morishita; N Sugiyama; K Yokochi; M Nakano; Y Wada; Y Hotta; A Terauchi; I Nonaka
Journal:  J Pediatr       Date:  1987-02       Impact factor: 4.406

6.  A mitochondrial encephalomyopathy with cardiomyopathy. A case revealing a defect of complex I in the respiratory chain.

Authors:  M Nishizawa; K Tanaka; K Shinozawa; T Kuwabara; T Atsumi; T Miyatake; E Ohama
Journal:  J Neurol Sci       Date:  1987-04       Impact factor: 3.181

7.  Congestive heart failure due to mitochondrial cardiomyopathy in Kearns-Sayre syndrome.

Authors:  F X Kleber; J W Park; G Hübner; A Johannes; D Pongratz; E König
Journal:  Klin Wochenschr       Date:  1987-05-15

8.  Mitochondrial encephalomyopathy. A variant with heart failure and liver steatosis.

Authors:  A Oldfors; M Tulinius; E Holme; H Kalimo; B Kristiansson; B O Eriksson
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 9.  Primary (genetic) cardiomyopathies in infancy. A survey of possible disorders and guidelines for diagnosis.

Authors:  A Kohlschütter; G Hausdorf
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

10.  A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q.

Authors:  J C Fischer; W Ruitenbeek; F J Gabreëls; A J Janssen; W O Renier; R C Sengers; A M Stadhouders; H J ter Laak; J M Trijbels; J H Veerkamp
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

View more
  7 in total

Review 1.  Inborn errors of metabolism as a cause of neurological disease in adults: an approach to investigation.

Authors:  R G Gray; M A Preece; S H Green; W Whitehouse; J Winer; A Green
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

2.  Giant Mitochondria as Possible Bioindicators of Environmental Injuries in Fish Liver.

Authors:  János Nemcsók
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

3.  Cardiovascular magnetic resonance imaging (CMR) reveals characteristic pattern of myocardial damage in patients with mitochondrial myopathy.

Authors:  Ali Yilmaz; Hans-Jürgen Gdynia; Matthias Ponfick; Sabine Rösch; Alfred Lindner; Albert C Ludolph; Udo Sechtem
Journal:  Clin Res Cardiol       Date:  2011-12-06       Impact factor: 5.460

4.  A splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher.

Authors:  Kathryn M Meurs; Sunshine Lahmers; Bruce W Keene; Stephen N White; Mark A Oyama; Evan Mauceli; Kerstin Lindblad-Toh
Journal:  Hum Genet       Date:  2012-03-25       Impact factor: 4.132

5.  Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup.

Authors:  Kevin A Strauss; Lauren DuBiner; Mariella Simon; Michael Zaragoza; Partho P Sengupta; Peng Li; Navneet Narula; Sandra Dreike; Julia Platt; Vincent Procaccio; Xilma R Ortiz-González; Erik G Puffenberger; Richard I Kelley; D Holmes Morton; Jagat Narula; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

6.  Clinical presentations of mitochondrial cardiomyopathies.

Authors:  D Lev; A Nissenkorn; E Leshinsky-Silver; M Sadeh; A Zeharia; B-Z Garty; L Blieden; V Barash; T Lerman-Sagie
Journal:  Pediatr Cardiol       Date:  2004-06-08       Impact factor: 1.655

Review 7.  Molecular Epidemiology of Mitochondrial Cardiomyopathy: A Search Among Mitochondrial and Nuclear Genes.

Authors:  Cristina Mazzaccara; Bruno Mirra; Ferdinando Barretta; Martina Caiazza; Barbara Lombardo; Olga Scudiero; Nadia Tinto; Giuseppe Limongelli; Giulia Frisso
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.